Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PD-1 Blockade Alone Versus in Combination With Chemotherapy as First Line Therapy in Females With Advanced NSCLC & PD-L1 Expression ≥50%

NCT07877584 is registered in ClinicalTrials.gov with German Cancer Research Center as lead sponsor.

NCT NCT07877584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07877584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PD-1 Blockade Alone Versus in Combination With Chemotherapy as First Line Therapy in Females With Advanced NSCLC & PD-L1 Expression ≥50%
Lead sponsor
German Cancer Research Center
Phase
Phase 3
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
November 30, 2033
Enrollment
406 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer